Nivolumab With or Without Ipilimumab or Chemotherapy in Treating Patients With Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Regeneron Pharmaceuticals
BeOne Medicines
University of Vermont
Merck Sharp & Dohme LLC
Hoffmann-La Roche
Bristol-Myers Squibb
Bristol-Myers Squibb
Bristol-Myers Squibb
Mayo Clinic
Bristol-Myers Squibb
Genfleet Therapeutics (Shanghai) Inc.
BeiGene
University Hospital, Limoges
Eli Lilly and Company
Ohio State University Comprehensive Cancer Center
Merck Sharp & Dohme LLC
EpicentRx, Inc.
Spanish Lung Cancer Group
National Cancer Institute (NCI)
BeiGene
EMD Serono
Novartis
AstraZeneca
Spanish Lung Cancer Group
Merck Sharp & Dohme LLC
Eli Lilly and Company
Memorial Sloan Kettering Cancer Center
Aetion, Inc.
Merck Sharp & Dohme LLC
Aetion, Inc.
Cantargia AB
Merck Sharp & Dohme LLC
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC
M.D. Anderson Cancer Center
Canadian Cancer Trials Group
Hoffmann-La Roche
Emory University
Bristol-Myers Squibb
EMD Serono
Canadian Cancer Trials Group
Canadian Cancer Trials Group
Cantargia AB
Eastern Cooperative Oncology Group
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)
Bristol-Myers Squibb
Intergroupe Francophone de Cancerologie Thoracique
Nektar Therapeutics